When I assumed the acting Fire Chief position, there were four available ambulances. Today, there are six, with more to come online by the end of this week. While we have made progress in returning ...
Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback